Thyroid C-mobile Tumors: In rodent reports, semaglutide has long been proven to trigger thyroid C-mobile tumors. It's not known no matter if this risk relates to individuals, but semaglutide is contraindicated in individuals with a private or loved ones history of medullary thyroid carcinoma (MTC) or people with Multiple Endocrine Neoplasia syndrom